Ripretinib - Deciphera Pharmaceuticals
At a glance
- Drug Originator Deciphera Pharmaceuticals
- Drug Licenced by GENESIS Pharma; Medison; Specialised Therapeutics Asia; ZAI Lab
- Drug Class Amines; Antineoplastics; Bromobenzenes; Cyclopropanes; Fluorinated hydrocarbons; Naphthyridines; Phenylurea compounds; Pyrazoles; Pyridines; Small molecules
- Mechanism of Action Platelet-derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein b-raf inhibitors; Proto-oncogene protein c-kit expression inhibitors; TIE-2 receptor antagonists; Vascular endothelial growth factor receptor-2 antagonists
- USA Patent Applicants DECIPHERA PHARMS
- USA Patents 43
- NDAs 1
- International Patents 104
- Patent Applications 51
Disclaimer